301 related articles for article (PubMed ID: 15847356)
1. Comparative evaluation of the efficacy and tolerability of itopride hydrochloride and domperidone in patients with non-ulcer dyspepsia.
Sawant P; Das HS; Desai N; Kalokhe S; Patil S
J Assoc Physicians India; 2004 Aug; 52():626-8. PubMed ID: 15847356
[TBL] [Abstract][Full Text] [Related]
2. Randomised, double-blind, comparative study to evaluate the efficacy and safety of ganaton (itopride hydrochloride) and mosapride citrate in the management of functional dyspepsia.
Amarapurkar DN; Rane P
J Indian Med Assoc; 2004 Dec; 102(12):735-7, 760. PubMed ID: 15871365
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of itopride hydrochloride in patients with non-ulcer dyspepsia.
Shenoy KT; Veenasree ; Leena KB
J Indian Med Assoc; 2003 Jun; 101(6):387-8. PubMed ID: 14579989
[TBL] [Abstract][Full Text] [Related]
4. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials.
Talley NJ; Tack J; Ptak T; Gupta R; Giguère M
Gut; 2008 Jun; 57(6):740-6. PubMed ID: 17965059
[TBL] [Abstract][Full Text] [Related]
5. A placebo-controlled trial of itopride in functional dyspepsia.
Holtmann G; Talley NJ; Liebregts T; Adam B; Parow C
N Engl J Med; 2006 Feb; 354(8):832-40. PubMed ID: 16495395
[TBL] [Abstract][Full Text] [Related]
6. Effects of itopride hydrochloride and ranitidine in patients with functional dyspepsia: comparison between prokinetic and acid suppression therapies.
Chiba T; Tokunaga Y; Ikeda K; Takagi R; Chishima R; Terui T; Kudara N; Endo M; Inomata M; Orii S; Suzuki K
Hepatogastroenterology; 2007 Sep; 54(78):1878-81. PubMed ID: 18019739
[TBL] [Abstract][Full Text] [Related]
7. [Use of itopride in the symptoms of functional dyspepsia in Russia: results of a phase IV prospective open-label multicenter clinical trial].
Kas'ianenko VI; Denisov NL; Vasil'ev IuV
Ter Arkh; 2014; 86(8):35-41. PubMed ID: 25306742
[TBL] [Abstract][Full Text] [Related]
8. Itopride in the treatment of functional dyspepsia in Chinese patients: a prospective, multicentre, post-marketing observational study.
Sun J; Yuan YZ; Holtmann G
Clin Drug Investig; 2011 Dec; 31(12):865-75. PubMed ID: 22035464
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of new gastro-intestinal prokinetic (ENGIP-II) study.
Walwaikar PP; Kulkarni SS; Bargaje RS
J Indian Med Assoc; 2005 Dec; 103(12):708-9. PubMed ID: 16821670
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of efficacy and tolerability of dothiepin hydrochloride in the management of major depression in patients suffering from rheumatoid arthritis.
Dhavale HS; Gawande S; Bhagat V; Durge V; Londhe V; Kini S; Nadkar MY; Borges NE
J Indian Med Assoc; 2005 May; 103(5):291-4. PubMed ID: 16229336
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of a fixed low-dose combination of cinnarizine and dimenhydrinate in the treatment of vertigo: a 4-week, randomized, double-blind, active- and placebo-controlled, parallel-group, outpatient study.
Pytel J; Nagy G; Tóth A; Spellenberg S; Schwarz M; Répassy G
Clin Ther; 2007 Jan; 29(1):84-98. PubMed ID: 17379049
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
13. Multicenter, randomized, double-blind, active-controlled, parallel-group trial of the long-term (6-12 months) safety of acetaminophen in adult patients with osteoarthritis.
Temple AR; Benson GD; Zinsenheim JR; Schweinle JE
Clin Ther; 2006 Feb; 28(2):222-35. PubMed ID: 16678643
[TBL] [Abstract][Full Text] [Related]
14. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.
Hiyama T; Yoshihara M; Matsuo K; Kusunoki H; Kamada T; Ito M; Tanaka S; Nishi N; Chayama K; Haruma K
J Gastroenterol Hepatol; 2007 Mar; 22(3):304-10. PubMed ID: 17295758
[TBL] [Abstract][Full Text] [Related]
16. Levosulpiride in functional dyspepsia: a multicentric, double-blind, controlled trial.
Corazza GR; Biagi F; Albano O; Bianchi Porro G; Cheli R; Mazzacca G; Miglio F; Naccarato R; Quaglino D; Surrenti C; Verme G; Gasbarrini G
Ital J Gastroenterol; 1996; 28(6):317-23. PubMed ID: 8891846
[TBL] [Abstract][Full Text] [Related]
17. [Levosulpiride versus domperidone in the treatment of functional dyspepsia].
Mangiameli A; Brogna A; Catanzaro R; Sofia M; Blasi A
Clin Ter; 1994 Feb; 144(2):107-14. PubMed ID: 7910127
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers.
Choung RS; Talley NJ; Peterson J; Camilleri M; Burton D; Harmsen WS; Zinsmeister AR
Neurogastroenterol Motil; 2007 Mar; 19(3):180-7. PubMed ID: 17300287
[TBL] [Abstract][Full Text] [Related]
19. Rabeto plus: a valuable drug for managing functional dyspepsia.
Ghosh A; Halder S; Mandal S; Mandal A; Basu M; Dabholkar P
J Indian Med Assoc; 2008 Nov; 106(11):752-4. PubMed ID: 19368103
[TBL] [Abstract][Full Text] [Related]
20. [A retrospective study on the efficacy of the treatment of functional dyspepsia. An evaluation of 166 cases].
Canepa G; Di Somma C; Arnulfo G; Frascio M; Berti Riboli E
Minerva Med; 1991 Jun; 82(6):371-3. PubMed ID: 2067709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
